Effects of pharmacist-driven protocol on naloxone prescribing rates in two primary care clinics
The Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain recommend co-prescribing naloxone as a harm reduction strategy when there is an increased risk of opioid overdose. Although naloxone co-prescribing is an important harm reduction strategy, many a...
| Main Authors: | , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Elsevier
2023-12-01
|
| 丛编: | Preventive Medicine Reports |
| 主题: | |
| 在线阅读: | http://www.sciencedirect.com/science/article/pii/S2211335523003844 |